PROCEPT BioRobotics Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, PROCEPT BioRobotics stock has a consensus rating of "Buy" and an average price target of $30.22. The average 1-year stock price forecast is 39.13% higher than the current stock price, while the lowest is $20 (-7.92%) and the highest is $37 (+70.35%).

Price Target: $30.22 (+39.13%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$20	$30.22	$30	$37
Change	-7.92%	+39.13%	+38.12%	+70.35%

Analyst Ratings

The average analyst rating for PROCEPT BioRobotics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	8	6	6	6	6	5
Buy	2	2	1	1	1	1
Hold	3	3	4	4	4	5
Sell	0	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	13	12	12	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mike Kratky Leerink Partners	Leerink Partners	Hold Downgrades $31 → $29	Hold	Downgrades	$31 → $29	+33.52%	Jun 11, 2026
Ryan Zimmerman BTIG	BTIG	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jun 3, 2026
Brandon Vazquez William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 3, 2026
Josh Jennings TD Cowen	TD Cowen	Buy Reiterates $34	Buy	Reiterates	$34	+56.54%	Jun 1, 2026
Stephanie Piazzola Bank of America Securities	Bank of America Securities	Sell Maintains $20	Sell	Maintains	$20	-7.92%	May 13, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

398.85M

from 308.05M

29.47%

from 308.05M

Revenue Next Year

491.56M

from 398.85M

23.24%

from 398.85M

EPS This Year

-1.52

from -1.72

EPS Next Year

-0.87

from -1.52

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	34.47M	75.01M	136.19M	224.50M	308.05M	398.85M
Revenue Growth	346.72%	117.60%	81.55%	64.84%	37.22%	29.47%
Gross Profit	15.87M	37.09M	71.05M	137.10M	196.23M	260.25M
Gross Margin	46.02%	49.44%	52.17%	61.07%	63.70%	65.25%
Operating Income	-54.16M	-80.72M	-109.17M	-96.61M	-103.86M	-91.79M
Net Income	-59.85M	-87.15M	-105.90M	-91.41M	-95.57M	-86.62M
EPS	-	-	-	-	-1.72	-1.52
Free Cash Flow	-36.81M	-53.06M	-106.37M	-78.24M	-23.92M	-28.40M
No. Analysts	-	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	403.3M
Avg	398.9M
Low	392.8M

Revenue Growth

Revenue Growth	2026	2027	2028
High	30.9%
Avg	29.5%
Low	27.5%

EPS Forecast

EPS	2026	2027	2028
High	-1.43
Avg	-1.52
Low	-1.61

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-